Instead of being in the "I'll take anything yesterday" crowd, like most here ...
I'd like to actually start a thread on SARS-CoV-2 vaccine options, especially since it looks like we'll be taking on SARS-CoV-2 on for a long time, so we'll have annual re-vaccinations.
Given the extremely limited, and poor results with those very recent, very limited, with mRNA trials prior to SARS-CoV-2, and the recent EMA leak that basically pointed out why the Europeans wouldn't have approved the Pfizer mRNA vaccine if people weren't dropping dead, I've really been looking at the Adenovirus Vectors options.
Now the Europeans have yanked the AztraZeneca Adenovirus option over blood clots, even though the statistics really don't support them being greater than nominal for just about any vaccine. I.e,. it's around only 1 in 400,000. That's actually lower than the mortality rate cataloged with the first 12M or so mRNA vaccines (around 1 in 50,000). But the Europeans are far more willing to do that, than us.
But that's not available in the US. What is available is the Johnson & Johnson (J&J) Adenovirus. I heard at least one person here has had it or is administering it. Kinda curious about their input too.
Related articles from European Regulators, Medical Aggregate Sites, Medical Journals and, in one case, Academia.
[European Regulator] Why SARS-CoV-2 is likely here to stay: https://horizon-magazine.eu/article/qa-why-history-suggests-covid-19-here-stay.html
[Aggregator] Vaccine Tracker (all vaccines, approved/locale, and in-dev): https://www.raps.org/news-and-articles/news-articles/2020/3/covid-19-vaccine-tracker
[Medical Journal] The BMJ Facts in the EMA Leak (Pfizer-related): https://www.bmj.com/content/372/bmj.n627
[Medical Journal] Adenovirus History, mostly Pros, but the infamous HIV Con: https://www.medpagetoday.com/podcasts/trackthevax/91323
[Academia] Adenovirus v. mRNA vaccines: https://theconversation.com/from-ad...f-different-covid-vaccine-technologies-145454
OT: Coronavirus Mega Thread
This is premium content. Please subscribe to view.
ucf.forums.rivals.com
I'd like to actually start a thread on SARS-CoV-2 vaccine options, especially since it looks like we'll be taking on SARS-CoV-2 on for a long time, so we'll have annual re-vaccinations.
Given the extremely limited, and poor results with those very recent, very limited, with mRNA trials prior to SARS-CoV-2, and the recent EMA leak that basically pointed out why the Europeans wouldn't have approved the Pfizer mRNA vaccine if people weren't dropping dead, I've really been looking at the Adenovirus Vectors options.
Now the Europeans have yanked the AztraZeneca Adenovirus option over blood clots, even though the statistics really don't support them being greater than nominal for just about any vaccine. I.e,. it's around only 1 in 400,000. That's actually lower than the mortality rate cataloged with the first 12M or so mRNA vaccines (around 1 in 50,000). But the Europeans are far more willing to do that, than us.
But that's not available in the US. What is available is the Johnson & Johnson (J&J) Adenovirus. I heard at least one person here has had it or is administering it. Kinda curious about their input too.
Related articles from European Regulators, Medical Aggregate Sites, Medical Journals and, in one case, Academia.
[European Regulator] Why SARS-CoV-2 is likely here to stay: https://horizon-magazine.eu/article/qa-why-history-suggests-covid-19-here-stay.html
[Aggregator] Vaccine Tracker (all vaccines, approved/locale, and in-dev): https://www.raps.org/news-and-articles/news-articles/2020/3/covid-19-vaccine-tracker
[Medical Journal] The BMJ Facts in the EMA Leak (Pfizer-related): https://www.bmj.com/content/372/bmj.n627
[Medical Journal] Adenovirus History, mostly Pros, but the infamous HIV Con: https://www.medpagetoday.com/podcasts/trackthevax/91323
[Academia] Adenovirus v. mRNA vaccines: https://theconversation.com/from-ad...f-different-covid-vaccine-technologies-145454